Related Experiment Videos
[Developments in drugs and populations at risk]
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|March 21, 1989
Summary
All drugs carry risks alongside benefits. A thorough risk-benefit analysis is crucial before initiating drug therapy, especially for newer medications, to manage adverse drug events and associated costs.
Area of Science:
- Pharmacology
- Drug Safety
- Health Economics
Context:
- The development of new drugs often yields therapeutic effectiveness alongside unwanted side-effects, a persistent challenge in modern medicine.
- Assessing the risk-benefit profile of any drug therapy is essential, particularly for recently introduced medications where tolerance data may be less defined than efficacy.
- Adverse drug events represent a significant socio-economic burden, with estimated annual costs in the USA reaching $3 million.
Purpose:
- To emphasize the critical need for comprehensive risk-benefit analyses in drug therapy.
- To highlight strategies for mitigating the negative impact of drug side-effects.
- To underscore the importance of pharmacovigilance and careful drug selection.
Summary:
- No drug is entirely without risk; effectiveness must be weighed against potential side-effects.
- Strategies such as reducing overall drug consumption, avoiding polypharmacy, adhering to strict indications, and enhanced surveillance for new drugs are vital.
- Special attention to at-risk populations is necessary to optimize patient outcomes and minimize adverse drug reactions.
Impact:
- Implementing these strategies can lead to safer medication practices and reduced healthcare costs associated with adverse drug events.
- Improved drug safety and judicious use of medications can enhance patient well-being and reduce the overall burden of disease.
- This approach supports evidence-based medicine by prioritizing patient safety and economic considerations in therapeutic decision-making.